−95.5
Xeris Biopharma Holdings, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−103
FY23:
−47.0
FY24:
−37.0
FY25:
28.6
Change from FY21 to FY25
millions USD
FY21:
98.0
FY22:
34.5
FY23:
−6.00
FY24:
4.88
FY25:
−0.70
Change from FY21 to FY25
millions USD
FY21:
27.2
FY22:
127
FY23:
−1.61
FY24:
36.2
FY25:
11.4
millions USD
FY21:
29.7
FY22:
59.0
FY23:
−54.6
FY24:
4.07
FY25:
39.3
(positive)
millions USD
FY21:
−96.6
FY22:
–
FY23:
–
FY24:
–
FY25:
–
All amounts in millions USD